Back to Treatments

Treatment

Faricimab

1
Conditions
26
Trials
10K
Participants
45%
Average Safety

Condition Evidence

Macular Degeneration

26 trials · 10K participants

90% effectiveness · 45% safety
Faricimab | DFDA